Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01507987 · ClinicalTrials.gov registry record
St.Jude Medical Cardiac Lead Assessment Study
A clinical trial, sponsored by Abbott Medical Devices.
- Completed
- Registry status
- 2,216
- Enrollment target
NCT01507987 is a clinical trial that has completed, run by Abbott Medical Devices. The registered enrollment target is 2,216 participants.
The verdict
NCT01507987 has completed, sponsored by Abbott Medical Devices.
- COMPLETED
- Registry status
- 2,216 participants
- Enrollment target
Study Summary
The Cardiac Lead Assessment Study (CLAS) is designed as a prospective, non-randomized, multi-center, international postmarket surveillance study under 522 Order PS120111 (August 16, 2012).
Interventions
- DEVICE Implanted with one or more of the following SJM leads: Riata leads, RiataST leads, Durata leads, and QuickSite/QuickFlex leads
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,216 participants |
| Start Date | 2013-03 |
| Est. Completion | 2019-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01507987
The ClinicalTrials.gov registry entry for NCT01507987 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 2,216 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Implanted with one or more of the following SJM leads: Riata leads, RiataST leads, Durata leads, and QuickSite/QuickFlex leads is the first listed.
NCT01507987 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01507987 about?
NCT01507987 is a clinical study titled "St.Jude Medical Cardiac Lead Assessment Study". The Cardiac Lead Assessment Study (CLAS) is designed as a prospective, non-randomized, multi-center, international postmarket surveillance study under 522 Order PS120111 (August 16, 2012).
What is the current status of trial NCT01507987?
This trial is currently completed. The enrollment target is 2,216 participants. The study started on 2013-03. Estimated completion is 2019-09.
What interventions are being tested in trial NCT01507987?
The interventions under investigation include: Implanted with one or more of the following SJM leads: Riata leads, RiataST leads, Durata leads, and QuickSite/QuickFlex leads (DEVICE).
Who is sponsoring clinical trial NCT01507987?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.